Indications
Therapeutic Asset Ratings
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fludarabine
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer Center
P2
BB
(71)
Fludarabine
Hematologic Disorder
Baptist Health South Florida
P2
BB
(71)
Fluorouracilum
Cancer Of Unknown Primary Site
Alliance for Clinical Trials in Oncology
P2
BB
(71)
Imatinib
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
The University of Hong Kong
P2
BB
(71)
Irinotecan
Pancreatic Acinar Cell Carcinoma
Artios Pharma Ltd
P2
BB
(71)
Irinotecan
Ovarian Carcinoma
OHSU Knight Cancer Institute
P2
BB
(71)
Mogamulizumab
Adult T-Cell Leukemia/Lymphoma
Memorial Sloan Kettering Cancer Center
P2
BB
(71)
Obinutuzumab
Richter Transformation
Christine Ryan
P2
BB
(71)
Pembrolizumab
Estrogen-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(71)
Pembrolizumab
Progesterone-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(71)
Tacrolimus
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
University of Michigan Rogel Cancer Center
P2
BB
(71)
Tacrolimus
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P2
BB
(71)
Tacrolimus
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P2
BB
(71)
Veliparib
Small Cell Lung Carcinoma
Central European Society for Anticancer Drug Research
P2
BB
(71)
Alemtuzumab
Chronic Myeloid Leukemia
Diane George
P2/3
BB
(71)
Atezolizumab
Metastatic Neoplasm
UNC Lineberger Comprehensive Cancer Center
P2/3
BB
(71)
Fludarabine
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P2/3
BB
(71)
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
Chronic Pain Syndrome
Second Affiliated Hospital, School of Medicine, Zhejiang University
P4
BB
(70)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Major Depressive Disorder
Western University, Canada
P4
BB
(70)
Abiraterone
Metastatic Prostate Carcinoma
Mayo Clinic
P4
BB
(70)
Adriamycin
Acute Lymphoblastic Leukemia
Princess Maxima Center for Pediatric Oncology
P4
BB
(70)
Adriamycin
ALK-Negative Anaplastic Large Cell Lymphoma
City of Hope Medical Center
P4
BB
(70)
Adriamycin
Angioimmunoblastic T-Cell Lymphoma
City of Hope Medical Center
P4
BB
(70)
Adriamycin
Breast Neoplasm
Merck Sharp & Dohme LLC
P4
BB
(70)
Adriamycin
Primary Central Nervous System Lymphoma
Juan P. Alderuccio, MD
P4
BB
(70)
Showing 1176 to 1200 of 42,327 assets
Previous
Page 48 of 1694
Next